Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant

Pseudomonas aeruginosa colistin pharmacokinetics pneumonia

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
09 Nov 2023
Historique:
medline: 9 11 2023
pubmed: 9 11 2023
entrez: 9 11 2023
Statut: aheadofprint

Résumé

The objective of this study was to examine the relationship between colistin plasma concentrations and clinical outcomes in patients with hospital-acquired pneumonia (HAP) caused by extensively drug-resistant

Identifiants

pubmed: 37943035
doi: 10.1128/spectrum.02967-23
pmc: PMC10715210
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0296723

Références

Clin Infect Dis. 2003 Dec 1;37(11):e154-60
pubmed: 14614688
Antimicrob Agents Chemother. 2009 Aug;53(8):3430-6
pubmed: 19433570
Clin Infect Dis. 2016 Jul 15;63(2):234-41
pubmed: 27098166
J Infect. 2019 Sep;79(3):253-261
pubmed: 31265867
J Chromatogr B Biomed Sci Appl. 2001 Sep 25;761(2):167-75
pubmed: 11587346
Clin Microbiol Infect. 2020 Sep;26(9):1275
pubmed: 32464182
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
J Antimicrob Chemother. 2019 May 1;74(5):1244-1252
pubmed: 30753505
BMC Infect Dis. 2017 Jan 5;17(1):11
pubmed: 28056821
Antimicrob Agents Chemother. 2014 Dec;58(12):7331-9
pubmed: 25267660
Int J Antimicrob Agents. 2018 Dec;52(6):828-834
pubmed: 30236956
Clin Infect Dis. 2016 Dec 23;64(5):565-571
pubmed: 28011614
Antimicrob Agents Chemother. 2010 Sep;54(9):3783-9
pubmed: 20585118
Lancet Infect Dis. 2018 Mar;18(3):285-295
pubmed: 29254862
Antimicrob Agents Chemother. 2011 Jul;55(7):3284-94
pubmed: 21555763
Int J Antimicrob Agents. 2016 Dec;48(6):725-727
pubmed: 28128096
Kidney Int. 2008 Mar;73(5):538-46
pubmed: 18160961
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28893780
Chest. 2010 Dec;138(6):1333-9
pubmed: 20558557
Molecules. 2019 Feb 01;24(3):
pubmed: 30717123
Antimicrob Agents Chemother. 2010 Mar;54(3):1117-24
pubmed: 20028824
Crit Care. 2015 May 06;19:219
pubmed: 25944081
Infection. 2009 Oct;37(5):461-5
pubmed: 19499183
Clin Infect Dis. 2017 Jul 1;65(1):110-120
pubmed: 29017262
BMC Infect Dis. 2013 Aug 19;13:380
pubmed: 23957376
Clin Microbiol Infect. 2020 Dec;26(12):1644-1650
pubmed: 32213316
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
J Antimicrob Chemother. 2015 Dec;70(12):3291-7
pubmed: 26318190
Clin Infect Dis. 2016 Dec 15;63(12):1615-1618
pubmed: 27624958
J Hosp Med. 2013 Oct;8(10):559-63
pubmed: 24022878
Pharmacotherapy. 2019 Jan;39(1):10-39
pubmed: 30710469
Chest. 2011 Jan;139(1):232-3; author reply 233-4
pubmed: 21208892
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Clin Infect Dis. 1999 May;28(5):1008-11
pubmed: 10452626
Lancet Infect Dis. 2019 Dec;19(12):1299-1311
pubmed: 31563344
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
Clin Infect Dis. 2016 Mar 1;62(5):552-558
pubmed: 26607424

Auteurs

Luisa Sorlí (L)

Infectious Diseases Service, Hospital del Mar, Barcelona, Spain.
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.

Sonia Luque (S)

CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.
Pharmacy Service, Hospital del Mar, Barcelona, Spain.
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.

Jian Li (J)

Infection Program and Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.

Adela Benítez-Cano (A)

Department of Anesthesiology and Surgical Intensive Care, Infectious Pathology and Antimicrobials Research Group, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.

Xenia Fernández (X)

Infection Program and Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.

Nuria Prim (N)

Microbiology Service, Laboratori de Referència de Catalunya, Barcelona, Spain.

Victoria Vega (V)

Analytical Department, Laboratori de Referència de Catalunya, Barcelona, Spain.

Joan Gómez-Junyent (J)

Infectious Diseases Service, Hospital del Mar, Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Inmaculada López-Montesinos (I)

Infectious Diseases Service, Hospital del Mar, Barcelona, Spain.

Silvia Gómez-Zorrilla (S)

Infectious Diseases Service, Hospital del Mar, Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.

M Milagro Montero (MM)

Infectious Diseases Service, Hospital del Mar, Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.

Santiago Grau (S)

Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.
Infection Program and Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.

Juan Pablo Horcajada (JP)

Infectious Diseases Service, Hospital del Mar, Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, Madrid, Spain.

Classifications MeSH